FDA Investigator Aimee Cunningham, PhD
Aimee Cunningham, PhD has inspections in 2 countries as of 13 Oct 2023. Aimee Cunningham, PhD has collaborated with a combinined 1502 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
Japan
Co-Investigator(s):
Amy Devlin, PhD,
Anastasia M Shields,
Anissa M Cheung,
Arie C Menachem,
Brenda P King,
Brentley S Collins,
Brently S Collins,
Brooke K Higgins,
Burnell M Henry,
Cheryl A Clausen,
Christian D Lynch (CDL),
Christina Capacci Daniel, PhD,
Christopher Downey, PhD,
Concepcion Cruz, Jr,
Dawn M Braswell,
Diane L Raccasi,
Dianne S Alexander,
Dr. Ralph M Bernstein, PhD,
Ekaterina Allen,
Ellen P Madigan,
Emest F Bizjak,
Erin L Mcfiren,
Gene D Arcy,
Ginger M Sykes,
Gunther Bockhoudt,
Gunther Boekhoudt, PhD,
Haoheng Yan, PhD,
Howard Anderson, PhD,
Jacqueline Mdiaz Albertini,
Jee Chung, PhD,
Jennifer Swisher, PhD,
Jonathan W Chapman,
Joyce A Rockwell,
Julie D Bringger,
Justine M Corson,
Kalavati Suvarna, PhD,
Kara A Scheibner, PhD,
Kathleen R Jones, PhD,
Laurie Nelson,
LCDR Debra Emerson,
Li Lu, PhD,
Maria Joselopez Barragan, PhD,
Marion Michaelis,
Martha T Olone,
Maxwell Van Tassell, PhD,
Megan A Haggerty,
Michael A Charles,
Michelle M Noe,
Monique C Lo,
Nailing Zhang,
Nancy G Schmidt,
Nebil A Oumer,
Omotunde O Osunsanmi,
Patricia Fhughes Troost,
Paul L Bellamy,
Paula A Trost,
Prabhu P Raju,
Priscilla M Pastrana,
Qin Xu,
Richard H Penta,
Richard W Thornton,
Rose M Ashley,
Russell J Glapion,
Sean R Marcsisin,
Sena G Dissmeyer,
Seth A Mailhot,
Stacey S Degarmo,
Steven Kozlowski, MD,
Steven P Donald,
Uttaniti Limchumroon (Tom),
Victor J Gangi,
Viviana Matta,
Walter Lange,
Wayne E Seifert,
Xu Michael Di, PhD,
Yanming An, PhD,
Yasamin Ameri,
Zhao Wang, PhD,
Zhihao Qiu (Peter), PhD,
Zhong Li, PhD
Aimee Cunningham, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| September, 2017 | FDA 483 | Chugai Pharma Manufacturing Co., Ltd - Form 483, 2017-09-01 |
| January, 2019 | FDA 483 | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Form 483, 2019-01-18 |
| January, 2019 | EIR | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - EIR, 2019-01-18 |
| January, 2019 | FDA 483 | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Form 483, 2019-01-17 |
| August, 2019 | EIR | AstraZeneca Pharmaceuticals LP - EIR, 2019-08-26 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more